About Clario
Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for life sciences companies. We offer comprehensive evidence-generation solutions that combine medical imaging, eCOA, precision motion, cardiac solutions and respiratory endpoints.
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have been deployed over 26,000 times to support clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2012. Clario's controlling shareholders are Astorg, Nordic Capital, Novo Holdings, and Cinven.
About NeuroRx
Founded in 2002 by Dr. Douglas Arnold, NeuroRx is an imaging provider with an unparalleled expertise in diseases impacting the Central Nervous System ("CNS"), such as multiple sclerosis, Huntington's, Parkinson's, Alzheimer's, and other rare neurological diseases. Since its founding, NeuroRx has supported clinical studies in 82 countries, and provided its expertise in over 300 clinical trials.
Back to HCB News
